ATH 25.0% 0.3¢ alterity therapeutics limited

Pivalde - As I have said before, I think this could end up as a...

  1. 1,847 Posts.
    lightbulb Created with Sketch. 1
    Pivalde - As I have said before, I think this could end up as a tropical disease application which would result in a voucher for priority review.

    Recent sales up to 245M for vouchers and tropical disease vouchers are largely underutilized.
    http://www.raps.org/Regulatory-Focu...Review-Voucher-for-Type-2-Diabetes-Treatment/
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.